In factor Xa inhibitor-related acute ICH, andexanet vs. usual care improved hemostatic efficacy but increased thrombotic events

Benton R Hunter; Jonathan M Kirschner

doi:10.7326/ANNALS-24-01365-JC

In factor Xa inhibitor-related acute ICH, andexanet vs. usual care improved hemostatic efficacy but increased thrombotic events

Ann Intern Med. 2024 Sep;177(9):JC101. doi: 10.7326/ANNALS-24-01365-JC. Epub 2024 Sep 3.

Authors

Benton R Hunter¹, Jonathan M Kirschner¹

Affiliation

¹ Indiana University School of Medicine, Indianapolis, Indiana, USA (B.R.H., J.M.K.).

PMID: 39222512
DOI: 10.7326/ANNALS-24-01365-JC

Abstract

Connolly SJ, Sharma M, Cohen AT, et al; ANNEXA-I Investigators. Andexanet for factor Xa inhibitor-associated acute intracerebral hemorrhage. N Engl J Med. 2024;390:1745-1755. 38749032.

Publication types

Comment